JHS Svendgaard Laboratories shareholders have approved a special resolution to modify the utilization of funds raised through a preferential issue of equity shares and fully convertible warrants. The resolution passed on July 29, 2026, with 99.89% of votes cast in favor, granting the company strategic flexibility to reallocate capital originally earmarked for specific purposes. This approval removes a key procedural hurdle, allowing management to adjust investment plans according to current market conditions and operational needs without seeking further shareholder consent for minor deviations.

The voting process concluded after a month-long remote e-voting period, overseen by Mohit Dahiya, Practicing Company Secretary of Dahiya & Associates, who served as the independent Scrutinizer. The Scrutinizer’s report, submitted on July 31, 2026, confirmed that the voting was conducted in compliance with Section 108 and Section 110 of the Companies Act, 2013, read with Rules 20 and 22 of the Companies (Management & Administration) Rules, 2014. National Securities Depository Limited (NSDL) provided the technical infrastructure for the e-voting facility.

Voting Results Breakdown

A total of 31,758,307 votes were polled out of 87,405,767 outstanding shares, representing a participation rate of 36.33%. The promoter group held 29,585,818 shares and voted unanimously in favor, while public non-institutional shareholders also supported the resolution with 98.44% affirmative votes.

The Board of Directors initiated the postal ballot process following a meeting on June 25, 2026. The notice was dispatched on June 29, 2026, with a cut-off date of June 26, 2026, for determining voting entitlements. Advertisements confirming the dispatch were published in Business Standard (Hindi & English) on June 30, 2026, as required under Rule 22 of the Companies (Management and Administration) Rules, 2014.

Regulatory Compliance and Next Steps

The proceedings adhered to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Secretarial Standard on General Meetings (SS-2). The company followed multiple Ministry of Corporate Affairs circulars, including General Circular Nos. 14/2020, 17/2020, 22/2020, 33/2020, 39/2020, 10/2021, 20/2021, 3/2022, 11/2022, 09/2023, 09/2024, and 03/2025, regarding e-voting procedures.

With the resolution deemed effective as of July 29, 2026, JHS Svendgaard Laboratories can now proceed with the modified utilization of funds. The company has uploaded the Scrutinizer’s report and voting results on its website and intimated the Bombay Stock Exchange and National Stock Exchange pursuant to Regulation 30 of the SEBI LODR Regulations.

JHS Svendgaard Laboratories Limited has initiated a postal ballot process to seek shareholder approval for revising the utilization of proceeds raised through a preferential issue. The total estimated utilization amount remains unchanged at ₹2,999.99 lakh, with funds proposed to be redirected towards broader capital expenditure, business expansion, and strategic growth initiatives by March 31, 2027.

The Board of Directors approved the variation at its meeting held on June 25, 2026, subject to shareholder consent. This modification amends the objects previously sanctioned via postal ballot on June 23, 2025, which had itself altered the original approval from the Extra-Ordinary General Meeting held on July 04, 2024. The company has engaged National Securities Depository Limited (NSDL) to facilitate the remote e-voting facility.

Voting Timeline and Process

The remote e-voting period commences on Tuesday, June 30, 2026, at 9:00 A.M. (IST) and concludes on Wednesday, July 29, 2026, at 5:00 P.M. (IST). The results of the postal ballot will be deemed passed on the last date of voting, subject to requisite majority approval. Members whose names appear in the register of members or beneficial owners as on Friday, June 26, 2026, are eligible to participate.

Mr. Mohit Dahiya, Company Secretary in Practice and Proprietor at M/s. Dahiya & Associates, has been appointed as the Scrutinizer to ensure the process is conducted fairly. The notice and explanatory statement are available on the company's website and the websites of BSE and NSE.

Revised Utilization Objects

The revised plan consolidates the earlier allocation into three primary categories, extending the tentative timeline for utilization to March 31, 2027. The tables below outline the existing and revised allocation structures.

Existing Objects (as approved on June 23, 2025):

*Considering 100% conversion of Warrants into Equity Shares within the stipulated time.

Objects After the Proposed Amendment:

*Considering 100% conversion of Warrants into Equity Shares within the stipulated time.

Key Objectives of the Amendment

Capital Expenditure and Business Expansion

Funds under this head will support capital expenditure, infrastructure upgradation, resource sharing, and manufacturing and business development initiatives. This category absorbs the previous allocation for equipment acquisition and expands the scope to include broader business development activities.

Strategic, Financial and Growth Initiatives

This category encompasses strategic investments, acquisitions, expansion initiatives, and restructuring activities. The company may deploy these funds directly or through investments in group companies via loans, advances, inter-corporate deposits, or equity, in compliance with applicable laws. The Board noted that the modification is clarificatory, intended to offer greater flexibility while achieving the original fundamental objectives.